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OBJECTIVE. AMI-227 is an ultrasmall superparamagnetic
iron oxide colloid known to enhance tissue TI and T2 relaxation rates. Animal studies show that AMI-227 has an estimated blood half-life of more than 200 mm. In this study, we evaluated the dinical utility of AMI-227 as an MR contrast agent for detection and characterization of focal hepatic lesions, with MR imaging done while the contrast agent is in the Intravascular space (blood-pool phase). [3, 6] . Therefore, although this compound is eventually cleared from the circulation by the reticuloendothelial system, immediately after infusion AMI-227 particles reside in the intravascular compartment or blood pool [3, 6] . In this initial study of patients, we evaluated the utility of AMI-227 as a blood-pool-based MR contrast agent for detection and characterization of focal hepatic lesions.
SUBJECTS AND METHODS. TWenty-two patients with known or suspected focal

Subjects and Methods
Twenty-two patients with known or suspected focal hepatic lesions were examined at two institutions. The study was approved by the institutional review boards, and informed consent was obtained from all patients. The study group included 12 men and 10 women with a mean age of 
Results
Solid Lesions
On Ti -weighted images (Fig. 1) (Fig. 2, top) , AMI-227 decreased signal in normal liver and blood vessels and therefore solid tumors became more conspicuous.
Differentiation between lesions and vessels Note that at this low dose, faint signal can be seen in intrahepatic blood vessels.
seen in cross section was also easier on the AMI-227 enhanced images.
In addition, phase-encoding artifacts due to high intravascular signal were reduced on T2-weighted images, which facilitated evaluation of the left hepatic lobe (Fig. 3) . The number of lesions seen and observers' confidence in identifying solid lesions was greater on contrast-enhanced images in seven of ii patients and similar to unenhanced images in the remaining four patients.
More lesions were visualized on contrast-enhanced images, with several presumed 5-mm metastases being identified with a high degree of confidence only on the contrastenhanced images (Fig. 3) . Similarly, lesion conspicuity was rated to be superior on contrast-enhanced images in nine of ii patients but was similar to unenhanced images in the remaining two patients. Readers' confidence in excluding lesions in apparently normal liver was superior on contrast-enhanced images in ii of 12 patients but was similar to unenhanced images in the remaining patient. Quantitatively, we found a statistically signif icant (p < .02) increase in tumor-liver CNR at all three doses for both Ti -and T2-weighted images (Table 1) .
Hemangiomas
On Ti -weighted images, hemangiomas enhanced (bloodpool effect) with lesions, becoming hyperintense relative to liver (Fig. 4, top) . On T2-weighted images, signal decreased in hemangiomas (Fig. 4, bottom) . Only at the highest dose was the decrease in blood signal complete and did hemangi- (Fig. 6 ). Small cysts (<5 mm), which had been seen on con- 
